Evidence map›Paper›PMID 26578674›Full record

ArticlemBio2015

The Complete Genome Sequence of the Emerging Pathogen Mycobacterium haemophilum Explains Its Unique Culture Requirements.

JoAnn M Tufariello, Christopher A Kerantzas, Catherine Vilchèze, R Brent Calder, Eric K Nordberg, Jack A Fischer, Travis E Hartman, Eva Yang, Timothy Driscoll, Laura E Cole and 4 more

Open access · goldAbstract read
In one paragraph

Article in mBio, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
17citing papers in PubMed, 1 pooled it
2.2field-weighted citation impact, top 12% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

17 citing papers in PubMed, 1 synthesis or guideline pooled it, 33 citations in OpenAlex.

  1. Pooled it
  2. Multifocal Cutaneous and MusculoskeletalCase reports in transplantation · 2026
    Article
  3. Article
  4. Article
  5. Article
  6. The Many Hosts of Mycobacteria 8 (MHM8): A conference report.Tuberculosis (Edinburgh, Scotland) · 2020
    Review
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Observational
  15. Fifteen-year clinical experience withJournal of clinical tuberculosis and other mycobacterial diseases · 2017
    Review
  16. Article
  17. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors at 4 institutions in 1 country.

JoAnn M TufarielloDepartment of Microbiology and Immunology, Albert Einstein College of Medicine, Bronx, New York, USA Department of Medicine, Albert Einstein College of Medicine, Bronx, New York, USA jacobsw@hhmi.org joann.tufariello@einstein.yu.edu.
Christopher A KerantzasDepartment of Microbiology and Immunology, Albert Einstein College of Medicine, Bronx, New York, USA.
Catherine VilchèzeDepartment of Microbiology and Immunology, Albert Einstein College of Medicine, Bronx, New York, USA Howard Hughes Medical Institute, Albert Einstein College of Medicine, Bronx, New York, USA.
R Brent CalderDivision of Computational Genetics, Department of Genetics, Albert Einstein College of Medicine, Bronx, New York, USA.
Eric K NordbergVirginia Bioinformatics Institute, Virginia Tech University, Blacksburg, Virginia, USA.
Jack A FischerDepartment of Microbiology and Immunology, Albert Einstein College of Medicine, Bronx, New York, USA.
Travis E HartmanDepartment of Microbiology and Immunology, Albert Einstein College of Medicine, Bronx, New York, USA.
Eva YangDepartment of Microbiology and Immunology, Albert Einstein College of Medicine, Bronx, New York, USA.
Timothy DriscollDepartment of Biology (Microbial Metagenomics), West Virginia University, Morgantown, Virginia, USA.
Laura E ColeDepartment of Microbiology and Immunology, Albert Einstein College of Medicine, Bronx, New York, USA.
Robert SebraDepartment of Genetics and Genomic Sciences, Icahn School of Medicine, Mount Sinai, New York, New York, USA.
Shahina B MaqboolEpigenomics Shared Facility, Albert Einstein College of Medicine, Bronx, New York, USA.
Alice R WattamVirginia Bioinformatics Institute, Virginia Tech University, Blacksburg, Virginia, USA.
William R JacobsDepartment of Microbiology and Immunology, Albert Einstein College of Medicine, Bronx, New York, USA Howard Hughes Medical Institute, Albert Einstein College of Medicine, Bronx, New York, USA jacobsw@hhmi.org joann.tufariello@einstein.yu.edu.
Albert Einstein College of Medicine · USVirginia Tech · USIcahn School of Medicine at Mount Sinai · USWest Virginia University · US

Funding

Molecular Genetic Analysis of Mycobacterium TuberculosisR37AI026170 · NIAID · ALBERT EINSTEIN COL OF MED YESHIVA UNIV · PI WILLIAM Robert JACOBS · 2004 to 2026
$7.7M
MOLECULAR GENETIC ANALYSIS OF MYCOBACTERIUM TUBERCULOSISR01AI026170 · NIAID · YESHIVA UNIVERSITY · PI JACOBS, WILLIAM ROBERT · 1989 to 2022
$7.1M
Vaccines for Extensively Drug Resistant TuberculosisR01AI098925 · NIAID · ALBERT EINSTEIN COLLEGE OF MEDICINE, INC · PI JACOBS, WILLIAM ROBERT · 2012 to 2016
$5.8M
Drugs targeting persistent Mycobacterium TuberculosisR01AI097548 · NIAID · ALBERT EINSTEIN COLLEGE OF MEDICINE, INC · PI JACOBS, WILLIAM ROBERT · 2013 to 2016
$2.6M
MOLECULAR GENETIC ANALYSIS OF MYCOBACTERIUM TUBERCULOSISR22AI026170 · NIAID · YESHIVA UNIVERSITY · PI JACOBS, WILLIAM ROBERT · 1989 to 1991
–
NIAID NIH HHS AI098925NIAID NIH HHS AI26170NIAID NIH HHS R01 AI026170NIAID NIH HHS R01 AI097548NIAID NIH HHS R01 AI098925NIAID NIH HHS R37 AI026170
6 · The paper itself

Abstract

unlabelledMycobacterium haemophilum is an emerging pathogen associated with a variety of clinical syndromes, most commonly skin infections in immunocompromised individuals. M. haemophilum exhibits a unique requirement for iron supplementation to support its growth in culture, but the basis for this property and how it may shape pathogenesis is unclear. Using a combination of Illumina, PacBio, and Sanger sequencing, the complete genome sequence of M. haemophilum was determined. Guided by this sequence, experiments were performed to define the basis for the unique growth requirements of M. haemophilum. We found that M. haemophilum, unlike many other mycobacteria, is unable to synthesize iron-binding siderophores known as mycobactins or to utilize ferri-mycobactins to support growth. These differences correlate with the absence of genes associated with mycobactin synthesis, secretion, and uptake. In agreement with the ability of heme to promote growth, we identified genes encoding heme uptake machinery. Consistent with its propensity to infect the skin, we show at the whole-genome level the genetic closeness of M. haemophilum with Mycobacterium leprae, an organism which cannot be cultivated in vitro, and we identify genes uniquely shared by these organisms. Finally, we identify means to express foreign genes in M. haemophilum. These data explain the unique culture requirements for this important pathogen, provide a foundation upon which the genome sequence can be exploited to improve diagnostics and therapeutics, and suggest use of M. haemophilum as a tool to elucidate functions of genes shared with M. leprae. IMPORTANCE: Mycobacterium haemophilum is an emerging pathogen with an unknown natural reservoir that exhibits unique requirements for iron supplementation to grow in vitro. Understanding the basis for this iron requirement is important because it is fundamental to isolation of the organism from clinical samples and environmental sources. Defining the molecular basis for M. haemophilium's growth requirements will also shed new light on mycobacterial strategies to acquire iron and can be exploited to define how differences in such strategies influence pathogenesis. Here, through a combination of sequencing and experimental approaches, we explain the basis for the iron requirement. We further demonstrate the genetic closeness of M. haemophilum and Mycobacterium leprae, the causative agent of leprosy which cannot be cultured in vitro, and we demonstrate methods to genetically manipulate M. haemophilum. These findings pave the way for the use of M. haemophilum as a model to elucidate functions of genes shared with M. leprae.

Indexed as

Genome, BacterialBase SequenceCulture MediaHemeHemoglobinsHumansIronMycobacterium haemophilumMycobacterium lepraeOxazolesPhenotypeSequence Analysis, DNACulture MediaHemeHemoglobinsIronmycobactinsOxazoles

Identifiers

PMID26578674
PMCPMC4659460
OpenAlexW2228868306

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-SA
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.